# Bio Green Med Solution, Inc.: filings

BGMS · Nasdaq · CIK 1130166 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bgms.md) · [Financials](/companies/bgms/financials.md) · [Filings](/companies/bgms/filings.md) · [Insiders](/companies/bgms/insiders.md)

## Reports and events: 425 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 291, 4 202, 10-Q 53, 424B3 53, CORRESP 47, SC 13G/A 31, UPLOAD 31, EFFECT 30, 3 28, POS AM 26, SC 13G 23, DEF 14A 22, 424B5 21, 10-K 18, DEFA14A 16, SCHEDULE 13G/A 16, S-1 11, S-1/A 11, S-8 11, ARS 8, D 8, 425 7, 3/A 6, 4/A 6, S-3 6, 10-K/A 5, PRE 14A 5, S-3/A 5, SCHEDULE 13G 4, 424B4 3, CT ORDER 3, DEF 14C 3, DRS 3, PRE 14C 3, RW 3, S-4/A 3, SC 13D 3, SCHEDULE 13D/A 3, 10-Q/A 2, 424B2 2, 5 2, 8-K/A 2, FWP 2, NT 10-Q 2, PRER14A 2, S-4 2, SC 13D/A 2, SCHEDULE 13D 2, DEFR14A 1, NT 10-K 1, S-1MEF 1, S-8 POS 1, SC 14F1 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-16 | 20:05 ET | [8-K](/filings/0001493152-26-047396.md) | 8.01 Other events | 0001493152-26-047396 |
| 2026-08-14 | 20:16 ET | [10-Q](/filings/0001493152-26-038393.md) | Quarterly report, period 2026-06-30 | 0001493152-26-038393 |
| 2026-08-14 | 01:37 ET | [8-K](/filings/0001493152-26-037902.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-037902 |
| 2026-07-01 | 20:05 ET | [8-K](/filings/0001493152-26-031542.md) | 8.01 Other events | 0001493152-26-031542 |
| 2026-06-22 | 10:10 ET | [8-K](/filings/0001493152-26-029452.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-029452 |
| 2026-06-10 | 16:47 ET | [8-K](/filings/0001493152-26-028072.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-028072 |
| 2026-06-04 | 20:45 ET | [8-K](/filings/0001493152-26-027291.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-027291 |
| 2026-05-15 | 20:16 ET | [10-Q](/filings/0001493152-26-023800.md) | Quarterly report, period 2026-03-31 | 0001493152-26-023800 |
| 2026-05-14 | 20:25 ET | [8-K](/filings/0001493152-26-023117.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-023117 |
| 2026-04-27 | 20:38 ET | [DEF 14A](/filings/0001493152-26-019158.md) | Proxy statement, period 2026-04-27 | 0001493152-26-019158 |
| 2026-04-13 | 15:51 ET | [8-K](/filings/0001493152-26-016325.md) | 8.01 Other events | 0001493152-26-016325 |
| 2026-03-30 | 21:43 ET | [10-K](/filings/0001493152-26-013669.md) | Annual report, period 2025-12-31 | 0001493152-26-013669 |
| 2026-03-30 | 21:36 ET | [8-K](/filings/0001493152-26-013611.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-013611 |
| 2026-03-13 | 14:30 ET | [8-K](/filings/0001493152-26-009991.md) | 3.01 Delisting notice | 0001493152-26-009991 |
| 2026-01-12 | 21:05 ET | [8-K](/filings/0001493152-26-001848.md) | 8.01 Other events | 0001493152-26-001848 |
| 2025-11-26 | 22:01 ET | [10-K/A](/filings/0001493152-25-025179.md) | Annual report, amended, period 2024-12-31 | 0001493152-25-025179 |
| 2025-11-13 | 23:00 ET | [SCHEDULE 13D/A](/filings/0001493152-25-022423.md) | Ownership report, active investor, amended | 0001493152-25-022423 |
| 2025-11-13 | 22:01 ET | [10-Q](/filings/0001493152-25-022388.md) | Quarterly report, period 2025-09-30 | 0001493152-25-022388 |
| 2025-11-13 | 21:50 ET | [8-K](/filings/0001493152-25-022378.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-022378 |
| 2025-11-06 | 23:00 ET | [8-K](/filings/0001493152-25-020920.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-25-020920 |
| 2025-10-07 | 13:01 ET | [8-K](/filings/0001493152-25-017224.md) | 8.01 Other events | 0001493152-25-017224 |
| 2025-10-07 | 13:00 ET | [8-K](/filings/0001493152-25-017223.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001493152-25-017223 |
| 2025-09-25 | 22:14 ET | [8-K](/filings/0001493152-25-014840.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-25-014840 |
| 2025-09-17 | 20:53 ET | [8-K/A](/filings/0001493152-25-013902.md) | 8.01 Other events | 0001493152-25-013902 |
| 2025-09-16 | 20:05 ET | [8-K](/filings/0001493152-25-013703.md) | 3.01 Delisting notice | 0001493152-25-013703 |
| 2025-09-12 | 10:07 ET | [8-K](/filings/0001493152-25-013123.md) | 2.01 Completion of an acquisition or disposition; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-013123 |
| 2025-09-05 | 15:53 ET | [8-K](/filings/0001641172-25-026676.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001641172-25-026676 |
| 2025-09-04 | 20:00 ET | [8-K](/filings/0001641172-25-026571.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001641172-25-026571 |
| 2025-09-02 | 10:02 ET | [8-K](/filings/0001641172-25-026110.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001641172-25-026110 |
| 2025-08-28 | 10:10 ET | [8-K](/filings/0001641172-25-025752.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001641172-25-025752 |
| 2025-08-14 | 01:45 ET | [10-Q](/filings/0001641172-25-023648.md) | Quarterly report, period 2025-06-30 | 0001641172-25-023648 |
| 2025-08-13 | 21:27 ET | [8-K](/filings/0001641172-25-023607.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-023607 |
| 2025-08-13 | 10:17 ET | [8-K](/filings/0001641172-25-023296.md) | 9.01 Financial statements and exhibits | 0001641172-25-023296 |
| 2025-08-08 | 14:52 ET | [SCHEDULE 13D/A](/filings/0000921895-25-002135.md) | Ownership report, active investor, amended | 0000921895-25-002135 |
| 2025-08-04 | 23:24 ET | [SCHEDULE 13D/A](/filings/0000921895-25-002083.md) | Ownership report, active investor, amended | 0000921895-25-002083 |
| 2025-07-31 | 00:31 ET | [S-1/A](/filings/0001641172-25-021610.md) | Registration statement, amended | 0001641172-25-021610 |
| 2025-07-28 | 20:06 ET | [8-K](/filings/0001641172-25-021159.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001641172-25-021159 |
| 2025-07-24 | 01:58 ET | [S-1](/filings/0001641172-25-020764.md) | Registration statement | 0001641172-25-020764 |
| 2025-07-16 | 13:00 ET | [8-K](/filings/0001641172-25-019834.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-019834 |
| 2025-07-07 | 10:04 ET | [8-K](/filings/0001641172-25-017906.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-017906 |
| 2025-07-02 | 13:00 ET | [8-K](/filings/0001641172-25-017479.md) | 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-017479 |
| 2025-06-30 | 20:28 ET | [8-K](/filings/0001641172-25-017152.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001641172-25-017152 |
| 2025-06-20 | 21:00 ET | [8-K](/filings/0001641172-25-015874.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-015874 |
| 2025-06-03 | 21:00 ET | [8-K](/filings/0001641172-25-013479.md) | 8.01 Other events | 0001641172-25-013479 |
| 2025-06-03 | 20:15 ET | [8-K](/filings/0001641172-25-013436.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-013436 |
| 2025-05-15 | 20:05 ET | [8-K](/filings/0001641172-25-010873.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-010873 |
| 2025-05-14 | 20:10 ET | [10-Q](/filings/0001641172-25-010270.md) | Quarterly report, period 2025-03-31 | 0001641172-25-010270 |
| 2025-05-07 | 15:00 ET | [8-K](/filings/0001641172-25-008988.md) | 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-008988 |
| 2025-05-06 | 20:05 ET | [8-K](/filings/0001641172-25-008836.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-008836 |
| 2025-04-25 | 20:10 ET | [8-K](/filings/0001641172-25-006201.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001641172-25-006201 |

Page 1 of 9. [Older](/companies/bgms/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:05 ET. No prices; not investment advice.